Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Heart education iPad app a first for BSX
Boston Scientific (NYSE:BSX) unveiled the industry’s first iPad app designed to help doctors educate patients about heart disease and treatments.
2. AdvaMed pushes for sunshine law
Medical device industry lobby AdvaMed urges the U.S. Dept. of Health & Human Services to fully implement a health care reform provision that would require companies to report payments made to physicians and teaching hospitals.
1. FDA panel says “Not yet” to MDT’s atrial fibrillation device
Medtronic’s (NYSE:MDT) cardiac ablation device is effective but too risky to approve for a type of atrial fibrillation, according to an FDA advisory panel. The FDA is not bound by its advisory panels’ recommendations, but it often follows their guidance.
